DRUG DISCOVERY DIGITAL EVENT PROGRAMME 2020Careers in Drug Discovery – CV Workshop Careers in Drug...

DRUG DISCOVERY DIGITAL

EVENT PROGRAMME2020

Welcome to Drug Discovery Digital

A very warm welcome to the first Drug Discovery Digital Conference! When we started planning the Drug Discovery 2020 event a year ago we were expecting to be welcoming you through the doors of London ExCel and would never have thought we would find ourselves conducting the meeting in a virtual environment. The world around us has changed dramatically since then, and we find ourselves in very challenging and uncertain times. With that ELRIG UK has also needed to evolve, but the need for connectivity and engagement across the life sciences and technology communities has never been stronger and the ELRIG team have worked incredibly hard to ensure that we maintain that connectivity through our webinar series and now at the first fully virtual ELRIG conference. ELRIG Drug Discovery Digital has all the components you would expect from an ELRIG DD

meeting, centred around a world class scientific programme of speakers, running across 8 tracks and 8 days so you no longer have to choose between your favourites! I would like to thank Chun-Wa Chung (GSK), Katy Kettleborough (LifeArc) and Ian Waddell (Charles River Laboratories), our conference directors, for their hard work to pull together such a outstanding programme. I would also like to thank each and every one of our speakers and session chairs for their contributions to the meeting and incredible flexibility in working with us to pivot a face to face programme to an online event over just a few short months.

Of course no ELRIG Drug Discovery meeting would be complete without a vendor exhibition and we are delighted to welcome so many vendor exhibitors and sponsors to the virtual exhibition floor within Drug Discovery Digital. ELRIG meetings could simply not take place without the support of our vendor sponsors and the interactions on the exhibition floor to discuss the latest technology breakthroughs and catch up with colleagues old and new are at the core of our meetings. Whilst it will feel somewhat different in the virtual environment, the online platform that the ELRIG team, together with our colleagues at Eventflo, have created is second to none and I encourage you to explore the exhibition and engage with the vendors just as you would at a face to face event, the only difference being that you can do it from the comfort of your home office, although unfortunately you will have to provide your own lunch!

Beyond the talks and the exhibition we also have a whole host of other activities for you to enjoy including the virtual poster sessions, interactive workshops and a number of events specifically for our Early Career Professional Community. Finally, we also have a couple of ‘Meet the ELRIG Board’ events where we would encourage you to come and say hi if you would like to know more about how you can get involved in the ELRIG UK volunteer community. We are looking for additional members for a number of our volunteer work groups, particularly, although not exclusively, from the early career professional community, and are always keen to have new faces and ideas on the team.

Finally, and most importantly, I would like to thank and congratulate the ELRIG office team led by Sanj Kumar, for their tireless efforts to put together this event. It is simply staggering what Sanj, together with Tara Shanks, Clare Cockerham and Rhona Bennett have achieved in such a short time frame this year, literally building the virtual event from scratch. I would also like to thank all of you for attending and your continued support of ELRIG UK. As we plan for further virtual events in early 2021 we would also very much welcome your feedback on what were your highlights of the event and if there are improvements we can make.

I hope you enjoy the event and I look forward to seeing you in the virtual sessions!

Melanie Leveridge(GlaxoSmithKline & ELRIG Chair)

Session ChairsWeek 1

Tuesday 6 October 2020 Better Hits = Better Therapeutics?Thomas Lundbäck (AstraZeneca) & Stephen Young (Sygnature Discovery)

Wednesday 7 October 2020

Innovations in Chemistry to Discover New MedicinesAndy Merritt (LifeArc) & David Andrews (Astrazeneca)

Thursday 8 October 2020

GPCRS in Drug Discovery hosted by the British Pharmacological SocietySarah Nickolls (GlaxoSmithKline) & David Kendall (PharmNovo)

Friday 9 October 2020

Addressing the Challenges of Infection – How do we Develop New Treatments?Fiona Marston (Liverpool School of Tropical Medicine) & Mike Dawson (Mike Dawson Antimicrobial Research Consultancy Ltd)

Week 2

Tuesday 13 October 2020

Patient Relevant Models for Drug DiscoveryJane Kendrew (Sygnature Discovery) & Antti Nurmi (Charles River Laboratories)


Multi Omic Approaches to Deliver New MedicinesGerard Drewes (GlaxoSmithKline) & Delphine Rolando (Benevolent Ai)

Thursday 15 October 2020 Novel approaches in oncology drug discovery, hosted by Cancer Research UK TrackTbc


New Modalities To Treat DiseaseMark Creighton-Gutteridge (GlaxoSmithKline) & David Blakey (MiNA Therapeutics)

Conference Directors

Catherine Kettleborough(LifeArc)

Chun-wa Chung(GlaxoSmithKline)

Ian Waddell(Charles River Laboratories)

Early Career Professional Activities: Pre-booking required

Workshop RoomsWednesday 7 October 2020 11:00 - 12:00 BSTFriday 16 October 2020 11:00 - 12:00 BST

CV Reviewers

Sue Ward (Illumina)Emma Howarth (Langton Howarth)Liliana Tomic (Sartorius)Jonathan Metters (Adepto Technical Recruitment)Declan Jones (Ferring Pharmaceuticals)Jarrod Walsh (AstraZeneca)Kate Snell (Perkin Elmer)Chun-wa Chung (GlaxoSmithKline)Clare Jones (Talisman Therapeutics)Matthew Burns (Laboratory Solutions Recruitment)

Careers in Drug Discovery – CV Workshop

Careers in Drug Discovery – Network Like a Boss

Workshop Room Friday 9 October 11:00 - 12:00 BSTWednesday 14 October 11:00 - 12:00 BST

Bosses

Nicholas Holliday (Excellerate Bioscience, Uni Nottingham)Elizabeth Rosethorne (Sygnature Discovery)Steve Rees (AstraZeneca)Jane Kendrew (Sygnature Discovery)Kirstie Bennet (Sosei Heptares)Sarah Nickolls (GlaxoSmithKline)Chun-wa Chung (GlaxoSmithKline)Lisa Stott (Sosei Heptares)Verena Brucklacher-Waldert (Horizon Discovery)Ayiba Momoh (Stem Cell Sciences)Duncan Borthwick (Solentim)Sorrel Bunting (British Pharmacological Society)Sonia Houghton (Cryoniss)David Loczenski (RenaSci)Pritom Shah (Cancer Research UK)Nicole Hamblin (Charles River)Zoe Zeliku (GlaxoSmithKline)Peter Blenkiron (Bayer)Richard Taylor (Bayer)Clare Szybut (Sartorius)David Pearson (Cambrex)Gerry Alden (Biosero Inc)Paul Watts (CBRE)

Sponsored by

Hot Topic Discussions: No pre-booking required

Pelago BioscienceOvercoming challenges in early lead generation - how to get ahead in drug discoveryWorkshop Room Wednesday 7 October 2020 14:20 - 15:20 BST

bit-bioSolving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions

Workshop Room Tuesday 13 October 2020 14:15 - 15:15 BST

CurioxHow to get the most from your oncology sample by going centrifuge freeWorkshop RoomThursday 15 October 2020 14:35 - 15:35 BST


Better Hits = Better Therapeutics?

Location: Conference Hall

10:00 - 10:10 Conference Welcome and Keynote IntroductionMelanie Leveridge (GlaxoSmithKline), Catherine Kettleborough (LifeArc), Ian Waddell (Charles River Laboratories) & Chun-wa Chung (GlaxoSmithKline)

10:10 - 11:00 Plenary KeynoteThe Path Less Travelled: From EastEnder to Footballer to Biotech EntrepreneurDr Darrin M Disley, OBE (Mogrify Limited)

11:00 - 11:30 Platinum Sponsor: Pelago Bioscience ABNavigate your chemistry and explore your biology with CETSAStina Lundgren & Michael Dabrowski (Pelago Biosciences AB)

11:30 - 11:35 Session Chair WelcomeThomas Lundbäck (Discovery Sciences, AstraZeneca) & Stephen Young (Sygnature Discovery)

11:35 - 12:05 When Choosing Hits, Remember the DestinationPaul Leeson (Paul Leeson Consulting)

12:05 - 12:20 Industry Insider Presentation: PerkinElmer | CisbioPerkinElmer’s Reagents + Microplates for Drug DiscoveryLouise Affleck (PerkinElmer | Cisbio)

12:20 - 12:50 Identifying and Characterising Desirable and Undesirable Mechanisms of Action (MoA) Post HTSGareth Davies (AstraZeneca)

12:50 - 13:30 Break & Exhibition Hall

13:30 - 14:00 Workshop Presentation: SartoriusTechnologies and solutions for the development of novel biopharmaceuticals – from molecule identification to cell line developmentHelge Schnerr (FortéBio) & Matthew Tomlinson (Sartorius)

14:00 - 14:15 Industry Insider Presentation Presentation: Sygnature DiscoveryBuilding a modern screening library and infrastructureStephen Young (VP Business Development, Sygnature Discovery)

14:15 - 14:45 The European Lead Factory: chemical diversity through sharing compound collectionsJeremy Davis (UCB)


15:30 - 16:00 The Discovery of Small molecule Inhibitors of TNF - Inhibiting Protein: Protein interactions with FragmentsJames O’Connell (UCB)

16:00 - 16:05 Technology Spotlight Presentation Increase your hits with laboratory automationNikolaus Machuy (Thermo Fisher Scientific)

16:05 - 16:10 Technology Spotlight Presentation Genedata Screener: Automating Complex Assay Analysis and Integrating Results for Pre-clinical Drug DiscoveryMark Brewer (Genedata AG)

16:10-16:15 Technology Spotlight Presentation Lumit™ Technology for Homogeneous Bioluminescent ImmunoassaysLucy Wheatley (Promega UK Ltd)

16:15 - 16:45 Leveraging high content and live cell imaging in primary and complex patient-derived models for drug repurposing and drug discoveryBrinton Seashore-Ludlow (Karolinska Institutet)


Innovations in Chemistry to Discover New Medicines


10:00 - 10:10 Conference Welcome and ECP Impact Award Winner IntroductionDel Trezise (Sartorius)

10:10 - 10:30 ECP Impact Award winner presentationBig Adventures in Tiny Lab Coats: Inspiring the next generation of drug discovery scientistsElaine Duncan (Charles River Laboratories)

10:30 - 10:35 Session Chair WelcomeDavid Andrews (AstraZeneca) & Andy Merritt (LifeArc)

10:35 - 11:00 AI-enabled generation of novel fragments using screening data, a hybrid SMILES autoencoder and transfer learningAlan Bilsland (CRUK Beatson Institute)

11:00 - 11:25 The Influence of Size, Shape, and Sociability in Fragment-Based Drug DiscoveryJeffrey St Denis (Astex Therapeutics)

11:25 - 11:40 Q & A Session

11:40 - 11:55 Industry Insider Presentation: Charles River LaboratoriesUse of the Developability Classicisation System to guide early stage development projectsDarren Matthews (Charles River Laboratories)


13:00 - 13:25 Activity-Directed Synthesis: A function-driven approach to drive lead generationAdam Nelson (University of Leeds)

13:25 - 13:50 Optimisation of inhibitors of the anti-infective target 1-deoxy-D-xylulose-5-phosphate synthase using target-directed dynamic combinatorial chemistryRavindra Jumde (Helmholtz Centre for Infection Research)

13:50 - 14:05 Q & A Session

14:05 - 14:20 Industry Insider Presentation: Beckman Coulter UK LtdEvotec Sample management: Evolution of our processes towards acoustic tube technologyPresenter invited by Beckman Coulter: Olivier Casamitjana (Evotec)


15:20 - 15:45 Hit Discovery in the European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening at Pivot Park Screening CentreSaman Honarnejad (Pivot Park Screening Centre)

15:45 - 16:10 Pursuit of a target class approach to kinases to facilitate lead and target identification and drive drug discovery innovationDavid Drewry (UNC Eshelman School of Pharmacy)

16:10-16:25 Q & A Session


GPCRS in Drug Discovery

Hosted by:


10:00 - 10:10 Conference Welcome and BPS Award Winner Introduction Rachel Lambert-Forsyth (British Pharmacological Society)

10:10 - 10:40 British Pharmacological Society - Sir James Black Award for Drug Discovery Professor Graham Russell (University of Oxford)

10:40 - 11:10 Platinum Sponsor: Promega UK LtdFluorescence and bioluminescence approaches to study the adenosine A2A receptor Leigh Stoddart (Promega UK Ltd)

11:10 - 11:15 Session Chair WelcomeSarah Nickolls (GlaxoSmithKline) & David Kendall (PharmNovo)

11:15 - 11:45 Lipid-responsive G protein-coupled receptors: established partners, some recent orphans and some awkward foster childrenSteve Alexander (University of Nottingham)

11:45 - 12:15 Profiling novel pharmacology of GPCR complexes using Receptor-HITKevin Pfleger (University of Western Australia)

12:15 - 13:15 Poster Session. Location: Poster Hall

13:15 - 14:15 Break & Exhbition Hall

14:15 - 14:45 Strategies to validate poorly characterised GPCRs: The case of GPR35Graeme Milligan (University of Glasgow)

14:45 - 15:00 Industry Insider Presentation Presentation: Twist BioscienceA High Throughput Platform to Develop Highly Potent and Functional Antibodies Against G-Pro-tein Coupled Receptors Pankaj Garg (Twist Bioscience)

15:00 - 15:30 Role and function of the GPR35/NaK-ATPase complexNicole Kaneider (University of Cambridge)

15:30 - 16:30 ELRIG/BPS Training Session: Safety Pharmacology in Drug Discovery and DevelopmentChris Pollard (Vivonics Preclinical)

16:30 - 17:00 In vitro Assays for Adhesion G Protein-Coupled ReceptorsSimon Dowell (GlaxoSmithKline)

17:00 - 17:30 Chemokine receptors: a valid therapeutic target?Anja Mueller (UEA)


Addressing the Challenges of Infection – How do we Develop New Treatments?


10:00 - 10:05 Session Chair Welcome Fiona Marston (Liverpool School of Tropical Medicine) & Michael Dawson (Mike Dawson Antimicrobial Research Consultancy Ltd)

10:05 - 10:35 Title TBCTim Jinks (Wellcome Trust)

10:35 - 10:40 Technology Spotlight PresentationALiCE®: Fast and scalable solutions to accelerate research Joanne Walter (LenioBio GmbH)

10:40 - 11:10 Discovering New Mechanism Antibiotics That Preserve the Human MicrobiomeDavid Powell (Summit Therapeutics Plc)

11:10 - 11:15 Technology Spotlight PresentationMethods in Imaging Flow Cytometry Data AnalysisBrian E. Hall (Luminex)

11:15 - 11:30 Meet the ELRIG Board


12:30 - 13:00 Evaluating the Utility of Machine Learning and AI in Antibiotic Drug DiscoveryPaul Finn (Oxford Drug Design)

13:00 - 13:15 Industry Insider Presentation Presentation: LifeArcFragment Based Target Screening – An empirical approach to prioritizing antibacterials targetsPeter Coombs (LifeArc)

13:15 - 13:45 Do we need precision dosing for antibiotics?Shampa Das (University of Liverpool)

13:45 - 14:15 SASPject: a novel antibacterial technologyHeather Fairhead (Phico Therapeutics)


Patient Relevant Models for Drug Discovery


10:00 - 10:10 Conference Welcome Chun-wa Chung (GlaxoSmithKline)

10:10 - 10:40 Platinum Sponsor: bit.bioConsistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery Thomas Moreau & Kam Dhaliwal (bit.bio)

10:40 - 10:45 Session Chair WelcomeJane Kendrew (Sygnature Discovery) & Antti Nurmi (Charles River Discovery Services, Finland)

10:45 - 11:15 Zebrafish Tumor Xenograft model: A new translational in-vivo tool for oncology drug discoveryAnna Erkstam (BioReperia AB)

11:15 - 11:30 Industry Insider Presentation: Emulate IncA human-based micro-engineered Colon Intestine-Chip to study mechanisms that drive epithelial barrier disruption and restitutionAthanasia Apostolou (Emulate Inc)

11:30 - 12:00 Preclinical models for ocular angiogenesisSimon Kaja (Experimentica Ltd)


13:00 - 13:30 Galleria mellonella as a novel in vivo drug discovery platform using bioluminescent KAPE pathogensOlivia Champion (Biosystems Technology)

13:30 - 13:45 Industry Insider Presentation Presentation: UPM BiomedicalsAdvanced Three Dimensional Cell-Based Assays for Drug Screening and Toxicity StudiesLauri Paasonen (UPM Biomedicals)

13:45 - 14:15 Preclinical Models: Are we asking the right questions?Keith Foster (University of Reading/Sutura Therapeutics)


15:15 - 15:45 Longitudinal characterization of the Cln8mnd-/- mouse model of CLN8 Batten Disease - fine motor performance, retinal degeneration, brain pathology and metabolic changesKimmo Lehtimaki (Charles River Laboratories)

15:45 - 15:50 Technology Spotlight Presentation Ensuring your cell based models remain relevant, by avoiding freeze-thaw; Atelerix’s encapsulation technology for room temperature storage and shipping of cells & tissuesSanj Kumar (Atelerix Ltd)

15:50 - 15:55 Technology Spotlight Presentation Clinically Relevant Models of OncologyJoe Lackey (LGC - ATCC)

15:55-16:00 Technology Spotlight Presentation Density-gradient-free solutions for cell isolationKristina Kremer (Miltenyi Biotec)

16:00 - 16:30 Rodent models of kidney disease: can we offer a reliable test platform to simulate human clinical trials?Wioletta Pijacka (RenaSci)


Multi Omic Approaches to Deliver New Medicines


10:00 - 10:10 Conference Welcome and Keynote IntroductionCatherine Kettleborough (LifeArc), Ian Waddell (Charles River Laboratories) & Chun-wa Chung (GlaxoSmithKline)

10:10 - 11:00 Plenary KeynoteGene targeting therapies for Huntington’s disease, what does the future hold for neurodegenera-tive disorders?Professor Sarah Tabrizi (UCL Queen Square Institute of Neurology)

11:00 - 11:05 Session Chair WelcomeGerard Drewes (GlaxoSmithKline) & Delphine Rolando (BenevolentAI)

11:05 - 11:35 A multi-omic approach to investigate variation in the host sepsis responseKatie Burnham (Sanger Institute)

11:35 - 11:50 Industry Insider Presentation: BD BiosciencesNext Gen Cytometry - increasing experimental power, reducing time to insightsHelen Smith (BD Biosciences)

11:50 - 12:20 Approaches to prioritize and modulate gene co-expression networks associated with diseasesPrashant Srivastava (Imperial College London)


13:20 - 13:50 Unravelling of new type 2 diabetes genes with 3D chromatin topology analysis and CRISPR/Cas9 perturbationsInes Cebola (Imperial College London)

13:50 - 14:05 Industry Insider Presentation Presentation: Beckman CoulterSARS-CoV-2 seroprevalence in a large populationPresenter invited by Beckman Coulter: Marc Emmenegger (University Hospital Zurich)

14:05 - 14:35 Endotype-driven target identification detection using omics dataAmparo Toboso-Navasa (BenevolentAI)


15:30 - 16:00 Multiplexed image-based drug screening in patient biopsies for personalized treatment discovery and systems medicineProfessor Berend Snijder (ETH Zurich)

16:00 - 16:05 Technology Spotlight Presentation Highly Efficient Miniaturization and Automation of Single-cell Omics WorkflowsAnna Oschowitzer (CELLINK)

16:05 - 16:35 Better patient stratification in cancer through multi-omics factor analysis (MOFA) Wolfgang Huber (EMBL)


Novel approaches in oncology drug discovery

Hosted by:


10:00 - 10:05 Session Chair Welcome

10:05 - 10:35 Platinum Sponsor: BioTek Instruments LtdThe Multi-faceted Assays Enabled with Cytation Technology: An Advanced Tool for Smarter Target-Based, Phenotypic Research & Screening Charles William Amirmansour (BioTek Instruments Ltd)

10:35 - 11:05 canSAR: a CRUK-funded, public, AI-powered platform for cancer drug discovery & translational researchBissan Al-Lazikani (Institute of Cancer Research)

11:05 - 11:20 Industry Insider Presentation Presentation: Charles River Laboratories In vitro cell based cytotoxicity and T cell activation assays to assess safety and efficacy of engineered T cell therapies Sanne Holt (Charles River Laboratories)

11:20 - 11:50 The Challenge of Functionally Inhibiting Arginase-2: Highly Specific Antibodies Created by Unbiased Affinity Maturation Daniel Burschowsky (University of Leicester) & Denice Chan (Cancer Research UK)

11:50 - 12:50 Poster Session. Location: Poster Hall


13:50 - 14:20 Development of first-in-class USP7 inhibitors using structure-based designAndrew Turnbull (Cancer Research UK Therapeutic Discovery Laboratories)

14:20 - 14:25 Technology Spotlight Presentation Next Generation Cancer Models from the HCMINirmal Perera (LGC - ATCC)

14:25 - 14:30 Technology Spotlight Presentation Building 3D healthy and tumour tissue models using peptide hydrogelsAline Miller (Manchester BIOGEL)

14:30 - 14:35 Technology Spotlight Presentation Amnis Imaging Flow Cytometry for deeper insights into mechanisms of actionOwen Hughes (Luminex)

14:35 - 15:05 Novel Therapeutics for Supratentorial EpendymomaLisa Ruff (Cancer Research UK)


15:30 - 16:00 FragLites: An experimental tool for assessing target druggability and validating computational approachesNatalie Tatum (University of Newcastle)

16:00 - 16:15 Industry Insider Presentation Presentation: CytivaCytiva & Cell DIVE for Cancer Research: Highly Multiplexed Immunofluorescent Imaging of tissue sections for spatial subcellular analysisMark Graham (Cytiva)

16:15 - 16:45 Picking up new interactions in the peptide binding site to generate cell-active inhibitors of BCL6Rosemary Huckvale (Institute of Cancer Research)


New Modalities to Treat Disease


10:00 - 10:05 Session Chair Welcome Mark Creighton-Gutteridge (GlaxoSmithKline) & David Blakey (MiNA Therapeutics)

10:05 - 10:35 Targeted Protein Degradation In Drug DiscoveryAgnieszka Konopacka (GlaxoSmithKline)

10:35 - 11:05 AUTO6NG overcomes immune suppressive mechanisms in the tumor microenvironment and demonstrates pre-clinical anti-tumor activity in GD2-expressing solid tumorsFred Arce Vargas (Autolus)

11:05 - 11:35 Platinum Sponsor: CurioxBiology at its best for all modalitiesSpeakers: Curiox Biosystems, Charles River, Adicet Bio & more


12:30 - 13:00 VEGF-A modified mRNA in Cardiovascular DiseaseAnna Collen (AstraZeneca)

13:00 - 13:30 Small activating RNAs – a novel therapeutic class of oligonucleotides with broad therapeutic potentialDavid Blakey (MiNA Therapeutics)

13:30 - 14:00 Next-Generation Bispecific Antibodies for Cancer ImmunotherapyMichelle Morrow (F-star Therapeutics)

14:00 - 14:30 Meet the ELRIG Board, Awards & Conference Close

PLATINUM SPONSORS

INDUSTRY INSIDERS

BioTek Instruments Ltd www.biotek.com

bit.biowww.bit.bio

Curiox Biosystems Ltd www.curiox.com

Sponsors , Exhibitors & Partners

Pelago Bioscience ABwww.pelagobio.com

Promega UK Ltd www.promega.co.uk

BD Bioscienceswww.bdbiosciences.com

Beckman Coulter www.beckmancoulter.com

Charles Riverwww.criver.com

Cytivawww.cytivalifesciences.com

Sygnature Discoverywww.sygnaturediscovery.com

Twist Biosciencewww.twistbioscience.com

UPM Biomedicalswww.upmbiomedicals.com

Emulate Incwww.emulatebio.com

LifeArcwww.lifearc.org

Luminexwww.luminexcorp.com

PerkinElmer | Cisbiowww.cisbio

WORKSHOP PRESENTERS

Sartoriuswww.sartorius.com

PREMIUM SPONSORS

EXHIBITORS

Atelerixwww.atelerix.co.uk

Cryoniss www.cryoniss.com

Genedatawww.genedata.com/screener

LenioBiowww.leniobio.com

LGC - ATCCwww.lgcstandards-atcc.org

Manchester BIOGELwww.manchesterbiogel.com

Miltenyi Biotecwww.miltenyibiotec.com

Thermo Fisher Scientificwww.thermofisher.com

AltemisLabwww.altemislab.com

ApconiX Limitedwww.apconix.com

CELLINKwww.cellink.com

Hamilton Sales & Service UK Ltdwww.hamiltoncompany.com

Kinomica Ltdwww.kinomica.com

Peak Proteins Ltdwww.peakproteins.com

STEMCELL Technologieswww.stemcell.com

PARTNERS

Biostratawww.bps.ac.uk

British Pharmacological Societywww.bps.ac.uk

Drug Discovery Newswww.apconix.com

Drug Discovery Worldwww.ddw-online.com

GlaxoSmithKline Careerswww.gsk.com/en-gb/careers

Technology Networkswww.technologynetworks.com

ELRIG EVENTS 2021

Research & Innovation 2021 Therapeutic Innovation for the New Decade 23-24 February 2021

CRISPR In Drug Discovery 2021From Targets to Therapeutics23-24 March 2021

Cell & Gene Therapy 2021AstraZeneca, Gothenburg, 18-19 May 2021

Translating Ideas into Therapies 2021 Co-Hosted with the British Pharmacological SocietyThe Francis Crick Institute, London28-29 June 2021

Drug Discovery 2021ACC, Liverpool19-20 October 2021

Advances in Cell-Based Screening 2021 With Chemical Biology Satellite MeetingAstraZeneca, Gothenburg 9-11 November 2021

Pharmaceutical Flow Cytometry & Imaging 2021Glaxosmithkline, Stevenage30 Nov- 1 Dec 2021

While ELRIG UK plan to run most of our 2021 events face-to-face, we will continue to observe government guidelines concerning the current global COVID-19 pandemic, therefore 2021 events may take place in-person, or virtually or as a hybrid of the two formats.

www.elrig.org

DRUG DISCOVERY DIGITAL EVENT PROGRAMME 2020Careers in Drug Discovery – CV Workshop Careers in Drug...

Documents

Transcript of DRUG DISCOVERY DIGITAL EVENT PROGRAMME 2020Careers in Drug Discovery – CV Workshop Careers in Drug...